AN2 Therapeutics, Inc. Common Stock
$4.90
-$0.44 (-8.24%)
$4.88Day Range$5.47
Key Statistics
Market Cap
$201.51M
Shares Outstanding
37.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Mar 25, 2022
Round Lot
100
Locale
US
Trading Data
Day Open
$5.39
Day High
$5.47
Day Low
$4.88
Volume
204.5K
VWAP
$5.10
Prev Close
$5.34
Transactions
--
Acc. Volume
--
About AN2 Therapeutics, Inc. Common Stock
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
PHARMACEUTICAL PREPARATIONSSIC 283421 employees1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025(650) 331-9090IPO Mar 25, 2022US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001880438
- Composite FIGI
- BBG00QYLYBK4
- Share Class FIGI
- BBG00QYLYBL3
- Ticker Root
- ANTX
- SIC Code
- 2834
About AN2 Therapeutics, Inc. Common Stock (ANTX) Stock
AN2 Therapeutics, Inc. Common Stock (ANTX) closed the 2026-09-17 session at $4.90, down 8.24% versus the previous close (-0.44). The stock opened at $5.39 and traded between $4.88 and $5.47 during that session. Session trading volume was 204K shares. The volume-weighted average price (VWAP) is $5.10.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
AN2 Therapeutics, Inc. Common Stock has a market capitalization of $201.5 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ANTX is listed on the XNAS exchange. The company employs approximately 21 people. AN2 Therapeutics, Inc. Common Stock is headquartered in MENLO PARK, CA. The recorded listing date is 2022-03-25.
On this page you can find market ANTX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.